Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2006; 12(31): 5060-5063
Published online Aug 21, 2006. doi: 10.3748/wjg.v12.i31.5060
Published online Aug 21, 2006. doi: 10.3748/wjg.v12.i31.5060
Table 3 Accumulated survival rate for 874 HCC patients after various kinds of interventional therapy
| Group | Cases(n) | 1 yr | 3 yr | 5 yr | |||
| Cases(n) | Survivalrate (%) | Cases(n) | Survivalrate (%) | Cases(n) | Survivalrate (%) | ||
| Preop. TACE | 198 | 148/198 | 74.7 | 82/198 | 41.4 | 58/157 | 36.9 |
| Postop.TACE | 114 | 90/114 | 78.9 | 46/114 | 40.4 | 33/88 | 37.5 |
| TACE + RFA | 106 | 79/106 | 74.5 | 39/106 | 36.8 | - | - |
| TACE | 387 | 268/387 | 69.3 | 84/387 | 21.7 | 26/309 | 8.4 |
| TAI | 69 | 8/69 | 11.6 | 0/69 | 0 | 0/69 | 0 |
| Total | 874 | 593/874 | 67.8 | 251/874 | 28.7 | 117/623 | 18.8 |
- Citation: Liu YM, Qin H, Wang CB, Fang XH, Ma QY. Comparison of therapeutic effectiveness of combined interventional therapy for 1126 cases of primary liver cancer. World J Gastroenterol 2006; 12(31): 5060-5063
- URL: https://www.wjgnet.com/1007-9327/full/v12/i31/5060.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i31.5060